http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5095027-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43acd1011dadef727551e4a34524c90c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 1991-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30741ffb539e5b3be644d71c8c9c78bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f7014b3ce10620519f742712e7ace33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdba444a1202af952343223fa00f0e27
publicationDate 1992-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5095027-A
titleOfInvention Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid
abstract The present invention provides a method for treating and/or reducing ischemic reperfusion injury. To this end, in embodiment, a method for treating and/or reducing reperfusion injury is provided comprising the step of administering to a patient in danger of reperfusion injury a therapeutically effective amount of L-2-oxothiazolidine-4-carboxylic acid. In an embodiment, a method is provided for limiting an expected ischemic reperfusion injury comprising the step of administering prior to an expected ischemic event a therapeutically effective amount of L-2-oxothiazolidine-4-carboxylic acid. In a further embodiment of the present invention, a method is provided for limiting ischemic reperfusion injury comprising the step of administering to a patient after the onset of an ischemic event a therapeutically effective amount of L-2-oxothiazolidine-4-carboxylic acid.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115245143-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5866595-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007232072-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5674857-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004206373-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5925658-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5208249-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005020077-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5306724-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5824693-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004206375-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005173253-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004222101-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5447712-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-663373-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9408612-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9417799-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7520939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5747459-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5389657-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5430045-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6413999-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10239847-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5498427-A
priorityDate 1991-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4665082-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0257992-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0318330-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4647571-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223926490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129672242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127809287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID347947778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223764812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306

Total number of triples: 89.